Costs of rheumatoid arthritis in Germany: A micro-costing approach based on healthcare payer's data sources

Annals of the Rheumatic Diseases

Volumn 62, Issue 6, 2003, Pages 544-550

  Ruof, J ^a   Hulsemann J L ^a   Mittendorf, T ^a,b   Handelmann, S ^a   Von Der Schulenburg, J M ^b   Zeidler, H ^a   Merkesdal, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ACCURACY; AGED; ARTICLE; COST OF ILLNESS; DATA BASE; EMPLOYMENT; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONEY; OUTPATIENT; PRIORITY JOURNAL; PRODUCTIVITY; RETIREMENT; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; WORK DISABILITY;

ADULT; AGED; AMBULATORY CARE; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIAGNOSTIC SERVICES; DIRECT SERVICE COSTS; DRUG COSTS; FEMALE; GERMANY; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PROSTHESES AND IMPLANTS; RETROSPECTIVE STUDIES; SICK LEAVE; WORKERS' COMPENSATION;

EID: 0037809623     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.6.544     Document Type: Article

References (21)

1. Merkesdal S, Ruof J, Mittendorf T, Mau W, Zeidler H. Health economic research in rheumatoid arthritis. Z Rheumatol 2002:61:21-9.
2. Kobelt G, Jonsson L, Mattiasson A. Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum 1999;42:347-56.
3. Clarke AE, Zowall H, Levinton C, Assimakopopoulos, Sibley JT, Haga M, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis. J Rheumatol 1997;24:1051-60.
4. Ruof J, Huelsemann JL, Stucki L. Evaluation of costs in rheumatic diseases: a literature review. Curr Opin Rheumatol 1999;11:104-9.
5. Merkesdal S, Ruof J, Schoeffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis. Arthritis Rheum 2001;44:528-34.
6. Yelin E, Wanke LA. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum 1999;42:1209-18.
7. Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
8. Van Jaarsveld CHM, Jacobs JWG, Schrijvers AJP, Heurkens AHM, Haanen HCM, Bijlsma JW. Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. Br J Rheumatol 1998;37:837-47.
9. Goossens MEJB, Rutten-van Moelken MPMH, Vlaeyen JWS, van der Linden SMJP. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000;53:688-95.
10. Ruof J, Merkesdal S, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, et al. Cost assessment instruments in rheumatology: evaluation of applied instrument characteristics. J Rheumatol 2001;28:662-5.
11. Merkesdal S, Ruof J, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, et al. Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. J Rheumatol 2001;28:657-61.
12. Uitz E, Fransen J, Langenegger T, Stucki G. Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis. Rheumatology (Oxford) 2000;39:542-9.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Russel[ LB, Siegel JE, Weinstein MC, eds. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996:176-213.
15. AOK. Die Gesundheitskasse für Niedersachsen. Geschäftsbericht 2000. Hannover: Grütter, 2001.
16. Mundenbruch R. BMAE, E-GO, EBM: Gegenüberstellung mit Abrechnungshinweisen. Dachau: Zeuner, Druck- und Verlags GmbH, 2000
17. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting. Arthritis Rheum 1997;40:1475-81.
18. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
19. Girard F, Guillemin F, Novella JL, Valckenaere I, Krzanowska K, Vitry F, et al. Health-care use by rheumatoid arthritis patients compared with non-arthritis subjects. Rheumatology (Oxford) 2002;41:167-75.
20. Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists. Arthritis Rheum 2001;44:1504-14.
21. Epstein AM, Stern RS, Weissman JS. Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources. N Engl J Med 1990;322:1122-8.